Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RISS Block for Postoperative Pain in Open Nephrectomy
NCT05301075Phase 1Unknown
- Sponsor
- Cairo University
- Start
- Mar 2022
- Primary completion
- Aug 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ropivacaine in postoperative pain, sponsored by Cairo University. Primary endpoint: Nalbuphine consumption at 24 hours. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05301075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05301075.